Clinical Trial Update: Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) [Phase 1, Phase 2]

View source ↗

Summary

A completed safety study of oral sodium phenylbutyrate in subjects with amyotrophic lateral sclerosis (Phase 1/Phase 2) sponsored by the US Department of Vetera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED